Process for improved protein expression by strain engineering

• US 8,603,824 B2
• Filed: 07/26/2005
• Issued: 12/10/2013
• Est. Priority Date: 07/26/2004
• Status: Active Grant

• Current Assignee: Pelican Technology Holdings, Inc (Primordial Genetics Inc.)
• Original Assignee: Pfenex Inc.
• Inventors: Ramseier, Thomas M., Jin, Hongfan, Squires, Charles H.
• Primary Examiner(s): Marvich, Maria
• Application Number:
  US11/189,375
• Publication Number:
  US 20060110747A1
• Time in Patent Office: 3,059 Days
• Field of Search: None
• US Class Current: 435/471
• CPC Class Codes: C12N 15/63 Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
• CPC Class Codes: C12N 15/70 Vectors or expression systems specially adapted for E. coli
• CPC Class Codes: C12N 15/74 Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
• CPC Class Codes: C12N 15/78 for Pseudomonas
• CPC Class Codes: C12P 21/02 having a known sequence of two or more amino acids, e.g. glutathione

Abstract

This invention is a process for improving the production levels of recombinant proteins or peptides or improving the level of active recombinant proteins or peptides expressed in host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recombinant protein expression. The process can improve protein production or can improve protein quality, for example, by increasing solubility of a recombinant protein.

Claims

1. A process for engineering a recombinant bacterial cell for expression of a recombinant protein or peptide, the process comprising:

i) obtaining a recombinant bacterial host cell comprising a nucleic acid encoding the recombinant protein or peptide operably linked to an expression control sequence operable in said recombinant bacterial host cell;

ii) expressing the recombinant protein or peptide in the recombinant bacterial host cell of step (i);

iii) analyzing a genetic profile of the recombinant bacterial host cell of step (ii), wherein said genetic profile comprises at least one gene encoding a protease and at least one gene encoding a folding modulator, to identify at least one protease and at least one folding modulator that are upregulated in the recombinant bacterial host cell of step (ii) relative to a gene product of the at least one protease gene and a gene product of the at least one folding modulator gene, in either a bacterial cell that has not been modified to express the recombinant protein or peptide, or a recombinant bacterial host cell that does not express the recombinant protein or peptide, wherein the genetic profile is a transcriptome profile;

iv) modifying the recombinant bacterial host cell of step (i) to increase the expression of the at least one upregulated folding modulator identified in step (iii) and to decrease the expression of the at least one upregulated protease identified in step (iii), by genetic modification to produce a modified recombinant bacterial host cell, wherein increasing the expression of the at least one upregulated folding modulator identified in step (iii) comprises introducing into the recombinant bacterial host cell of step (i) a DNA encoding the at least one upregulated folding modulator identified in step (iii), wherein the DNA encoding the at least one upregulated folding modulator is operably linked to an expression control sequence operable in the recombinant bacterial host cell into which it is introduced, and expressing the DNA encoding the at least one upregulated folding modulator identified in step (iii);

v) expressing the recombinant protein or peptide in the modified recombinant bacterial host cell of step (iv);

vi) analyzing a genetic profile of the modified recombinant bacterial host cell of step (v), wherein the genetic profile of the modified recombinant bacterial host cell of step (v) comprises at least one gene encoding a protease and at least one gene encoding a folding modulator, to identify at least one protease and at least one folding modulator that are upregulated in the modified recombinant bacterial host cell of step (v) relative to a gene product of the at least one protease gene and a gene product of the at least one folding modulator gene in a bacterial cell that has not been modified to express the recombinant protein or peptide, a recombinant bacterial host cell that does not express the recombinant protein or peptide, or a modified recombinant bacterial host cell that does not express the recombinant protein or peptide, wherein the genetic profile is a transcriptome profile;

vii) modifying the modified recombinant bacterial host cell of step (iv) to increase the expression of the at least one upregulated folding modulator identified in step (vi) and to decrease the expression of the at least one upregulated protease identified in step (vi), in the modified recombinant host cell to produce a multiply modified recombinant bacterial host cell;

viii) expressing the recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (vii);

ix) measuring the amount of soluble and active recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (viii) and in the recombinant bacterial host cell of step (ii); and

,

x) comparing the amount of soluble and active recombinant protein or peptide measured in the multiply modified recombinant bacterial host cell of step (viii) to the amount of soluble and active recombinant protein or peptide measured in the recombinant bacterial host cell of step (ii);

—

wherein

a. the measured amount of soluble and active recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (viii) is increased relative to the measured amount of soluble and active recombinant protein or peptide in the recombinant bacterial host cell of step (ii);

or

b. the measured amount of soluble and active recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (viii) is not increased relative to the measured amount of soluble and active recombinant protein or peptide in the recombinant bacterial host cell of step (ii), and wherein steps (v) through (ix) are repeated until the amount of soluble and active recombinant protein or peptide is increased relative to the measured amount of soluble and active recombinant protein or peptide in the recombinant bacterial host cell of step (ii);

wherein a cell comprising the increased amount of the soluble and active recombinant protein or peptide is the engineered recombinant bacterial cell.

2. The process of claim 1 wherein viability of the engineered, recombinant bacterial host cell is altered by the modification(s).

3. The process of claim 1 wherein the analysis of claim 1, step (iii), claim 1, step (vi), or both, further comprises identifying an upregulated gene product selected from the group consisting of:

a subunit of a protease, a homologous analog of a protease, a cofactor of a protease, a cellular modulator affecting expression of a protease, and a genetic modulator affecting expression of a protease, and wherein the modification of step (iv) and step (vii) requires increasing the level of the further identified upregulated gene product.

4. The process of claim 1 wherein the at least one protease that is encoded by the at least one protease gene in step (iii), step (vi), or both is a D alanyl-meso-diaminopimelate endopeptidase, a zinc protease, a microsomal dipeptidase, an extracellular metalloprotease precursor, a protease expressed from the gene hslV, a protease expressed from the gene hslU, a protease expressed from the gene clpX, a protease expressed from the gene clpA, or a protease expressed from the gene clpB.

5. The process of claim 1 wherein step (iii), step (vi), or both comprises analyzing the level(s) of the at least one protease cDNA to determine whether the at least one protease cDNA level is upregulated when the recombinant protein or peptide is expressed.

6. The process of claim 1 wherein decreasing the expression of the at least one protease in step (iv), step (vii), or both, comprises removing a sequence encoding all or part of the at least one protease from the genome of the recombinant bacterial host cell of step (i), the modified recombinant bacterial host cell of step (iv), or both.

7. The process of claim 6 wherein the sequence encoding all or part of the protease is removed by homologous recombination.

8. The process of claim 1 wherein the analysis of claim 1, step (iii), step (vi) or both further comprises identifying an upregulated gene product selected from the group consisting of:

a subunit of a folding modulator, a putative folding modulator, a cofactor of a folding modulator, a cellular modulator affecting the expression of a folding modulator, and a genetic modulator affecting the expression of a folding modulator, and wherein the modification of step (iv) and step (vii) requires increasing the level of the further identified upregulated gene product.

9. The process of claim 1 wherein the at least one folding modulator that is encoded by the at least one folding modulator gene in step (iii), step (vi), or both is a chaperone protein.

10. The process of claim 1 wherein the at least one folding modulator that is encoded by the at least one folding modulator gene in step (iii), step (vi), or both, is a folding modulator expressed from the gene cbpA, the gene htpG, the gene dnaK, the gene dnaJ, the gene fkbP2, the gene groES, or the gene groEL.

11. The process of claim 1 wherein increasing the expression of the at least one upregulated folding modulator in step (vii) comprises:

a) introducing into the modified recombinant bacterial host cell of step (iv) a DNA encoding the at least one upregulated folding modulator identified in step (vi), wherein the DNA encoding the at least one upregulated folding modulator identified in step (vi) is operably linked to an expression control sequence operable in the recombinant bacterial host cell into which it is introduced; and

b) expressing from the introduced DNA the at least one upregulated folding modulator identified in step (vi).

12. The process of claim 1 wherein increasing the expression of the at least one upregulated folding modulator in step (iv), step (vii), or both, comprises insertion of a promoter into the genome of the recombinant bacterial host cell of step (i) the modified bacterial host cell of step (iv), or both, respectively, wherein the promoter is operable in the recombinant bacterial host cell into which it is introduced, and wherein the promoter is inserted in a genomic location sufficient to control expression of said at least one folding modulator of step (iv), (vii), or both.

13. The process of claim 1 wherein increasing the expression of the at least one upregulated folding modulator in step (iv), (vii), or both, comprises:

a) introducing into the recombinant bacterial host cell of step (i), the modified recombinant bacterial host cell of step (iv), or both, an exogenous vector comprising a nucleotide sequence encoding said at least one folding modulator operably linked to an expression control sequence operable in the recombinant bacterial host cell into which it is introduced; and

b) expressing from the nucleotide sequence encoding the at least one folding modulator on the introduced exogenous vector said at least one upregulated folding modulator.

14. The process of claim 1 wherein the genetic profile in step (iii), step (vi), or both, is a profile of genes in a gene family.

15. The process of claim 1 wherein the transcriptome profile(s) is determined through a microarray.

16. The process of claim 15 wherein the microarray comprises:

binding partners for at least 50% of a genome of the recombinant bacterial host cell of step (i);

binding partners for at least 80% of a genome of the recombinant bacterial host cell of step (i);

binding partners for at least 90% of a genome of the recombinant bacterial host cell of step (i);

or binding partners for at least 95% of a genome of the recombinant bacterial host cell of step (i).

17. The process of claim 1 wherein the recombinant bacterial host cell of step (i) is a recombinant Pseudomonad cell.

18. The process of claim 17 wherein the recombinant bacterial host cell of step (i) is a recombinant Pseudomonas cell.

19. The process of claim 18, wherein the recombinant bacterial host cell of step (i) is a recombinant Pseudomonas fluorescens cell.

20. The process of claim 1 wherein the recombinant bacterial host cell of step (i) is a recombinant E. coli cell.

21. A process for engineering a recombinant bacterial cell for expression of a recombinant protein or peptide, the process comprising:

i) obtaining a recombinant bacterial host cell comprising a nucleic acid encoding the recombinant protein or peptide operably linked to an expression control sequence operable in said recombinant bacterial host cell;

ii) expressing the recombinant protein or peptide in the recombinant bacterial host cell of step (i);

iii) analyzing a genetic profile of the recombinant bacterial host cell of step (ii), wherein said genetic profile comprises at least one gene encoding a folding modulator, to identify at least one folding modulator that is upregulated in the recombinant bacterial host cell of step (ii) relative to a gene product of the at least one folding modulator gene, in either a bacterial cell that has not been modified to express the recombinant protein or peptide, or a recombinant bacterial host cell that does not express the recombinant protein or peptide, wherein the genetic profile is a transcriptome profile;

iv) modifying the recombinant bacterial host cell of step (i) to increase the expression of the at least one upregulated folding modulator identified in step (iii), by genetic modification to produce a modified recombinant bacterial host cell, wherein increasing the expression of the at least one upregulated folding modulator identified in step (iii) comprises introducing into the recombinant bacterial host cell of step (i) a DNA encoding the at least one upregulated folding modulator identified in step (iii), wherein the DNA encoding the at least one upregulated folding modulator is operably linked to an expression control sequence operable in the recombinant bacterial host cell into which it is introduced; and

expressing the DNA encoding the at least one upregulated folding modulator identified in step (iii);

v) expressing the recombinant protein or peptide in the modified recombinant bacterial host cell of step (iv);

vi) analyzing a genetic profile of the modified recombinant bacterial host cell of step (v), wherein the genetic profile of the modified recombinant bacterial host cell of step (v) comprises at least one gene encoding a folding modulator, to identify at least one folding modulator that is upregulated in the modified recombinant bacterial host cell of step (v) relative to a gene product of the at least one folding modulator gene, in a bacterial cell that has not been modified to express the recombinant protein or peptide, a recombinant bacterial host cell that does not express the recombinant protein or peptide, or a modified recombinant bacterial host cell that does not express the recombinant protein or peptide, wherein the genetic profile is a transcriptome profile;

vii) modifying the modified recombinant bacterial host cell of step (iv) to increase the expression of the at least one upregulated folding modulator identified in step (vi), in the modified recombinant host cell to produce a multiply modified recombinant bacterial host cell;

viii) expressing the recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (vii);

ix) measuring the amount of soluble and active recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (viii) and in the recombinant bacterial host cell of step (ii); and

,

x) comparing the amount of soluble and active recombinant protein or peptide measured in the multiply modified recombinant bacterial host cell of step (viii) to the amount of soluble and active recombinant protein or peptide measured in the recombinant bacterial host cell of step (ii);

wherein

a. the measured amount of soluble and active recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (viii) is increased relative to the measured amount of soluble and active recombinant protein or peptide in the recombinant bacterial host cell of step (ii);

or

b. the measured amount of soluble and active recombinant protein or peptide in the multiply modified recombinant bacterial host cell of step (viii) is not increased relative to the measured amount of soluble and active recombinant protein or peptide in the recombinant bacterial host cell of step (ii), and wherein steps (v) through (ix) are repeated until the amount of soluble and active recombinant protein or peptide is increased relative to the measured amount of soluble and active recombinant protein or peptide in the recombinant bacterial host cell of step (ii);

wherein a cell comprising the increased amount of the soluble and active recombinant protein or peptide is the engineered recombinant bacterial cell.

22. The process of claim 21 wherein increasing the expression of the at least one upregulated folding modulator in step (vii) comprises:

a) introducing into the modified recombinant bacterial host cell of step (iv) a DNA encoding the at least one upregulated folding modulator identified in step (vi), wherein the DNA encoding the at least one upregulated folding modulator is operably linked to an expression control sequence operable in the recombinant bacterial host cell into which it is introduced; and

b) expressing from the introduced DNA the at least one upregulated folding modulator identified in step (vi).

23. The process of claim 21 wherein viability of the engineered, recombinant bacterial host cell is altered by the modification(s).

24. The process of claim 21 wherein the analysis of claim 21, step (iii), step (vi) or both further comprises identifying an upregulated gene product selected from the group consisting of:

a subunit of a folding modulator, a putative folding modulator, a cofactor of a folding modulator, a cellular modulator affecting the expression of a folding modulator, and a genetic modulator affecting the expression of a folding modulator, and wherein the modification of step (iv) and step (vii) requires increasing the level of the further identified upregulated gene product.

25. The process of claim 21 wherein the at least one folding modulator that is encoded by the at least one folding modulator gene in step (iii), step (vi), or both, is a chaperone protein.

26. The process of claim 21 wherein the at least one folding modulator that is encoded by the at least one folding modulator gene in step (iii), step (vi), or both, is a folding modulator expressed from the gene cbpA, the gene htpG, the gene dnaK, the gene dnaJ, the gene fkbP2, the gene groES, or the gene groEL.

27. The process of claim 21 wherein increasing the expression of the at least one upregulated folding modulator in step (iv), step (vii), or both, comprises insertion of a promoter into the genome of the recombinant bacterial host cell of step (i), the modified recombinant bacterial host cell of step (iv), or both, respectively, wherein the promoter is operable in the recombinant bacterial host cell into which it is introduced, and wherein the promoter is inserted in a genomic location sufficient to control expression of said at least one folding modulator of step (iv), (vii), or both.

28. The process of claim 21 wherein increasing the expression of the at least one upregulated folding modulator in step (iv), step (vii), or both, comprises:

a) introducing into the recombinant bacterial host cell of step (i), the modified recombinant bacterial host cell of step (iv), or both, an exogenous vector comprising a nucleotide sequence encoding said at least one folding modulator operably linked to an expression control sequence operable in the recombinant bacterial host cell into which it is introduced; and

b) expressing from the nucleotide sequence encoding the at least one upregulated folding modulator on the introduced exogenous vector said at least one upregulated folding modulator.

29. The process of claim 21 wherein the recombinant bacterial host cell of step (i) is a recombinant Pseudomonad cell.

30. The process of claim 29 wherein the recombinant bacterial host cell of step (i) is a recombinant Pseudomonas cell.

31. The process of claim 30, wherein the recombinant bacterial host cell of step (i) is a recombinant Pseudomonas fluorescens cell.

32. The process of claim 21 wherein the recombinant bacterial host cell of step (i) is a recombinant E. coli cell.

33. The process of claim 21 wherein the transcriptome profile(s) is determined through a microarray.

34. The process of claim 33 wherein the microarray comprises:

binding partners for at least 50% of a genome of the recombinant bacterial host cell of step (i);

binding partners for at least 80% of a genome of the recombinant bacterial host cell of step (i);

binding partners for at least 90% of a genome of the recombinant bacterial host cell of step (i);

or binding partners for at least 95% of a genome of the recombinant bacterial host cell of step (i).

35. The process of claim 21 wherein the genetic profile in step (iii), step (vi), or both, is a profile of genes in a gene family.